Suppr超能文献

视网膜分支动脉与视网膜中央静脉联合阻塞:一项系统评价

Combined Branch Retinal Artery and Central Retinal Vein Occlusion: A Systematic Review.

作者信息

Pinna Antonio, Zinellu Angelo, Serra Rita, Boscia Giacomo, Ronchi Lorenza, Dore Stefano

机构信息

Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.

Ophthalmology Unit, Azienda Ospedaliero-Universitaria di Sassari, 07100 Sassari, Italy.

出版信息

Vision (Basel). 2023 Jul 28;7(3):51. doi: 10.3390/vision7030051.

Abstract

We performed a systematic review and analyzed the current available data on branch retinal artery occlusion (BRAO) with simultaneous central retinal vein obstruction (CRVO), a rarely described occurrence. MEDLINE/PubMed and ISI Web of Sciences searches were performed according to MOOSE guidelines. Studies were considered eligible if they (1) described patients with simultaneous BRAO + CRVO and (2) had been published in peer-reviewed journals. We initially identified 239 records from databases. Ultimately, only 19 reports met the selection criteria. Twenty-nine patients (15 men, 14 women; mean age 43 ± 15 years) were analyzed. Seventeen (59%) patients presented vascular risk factors. Mean visual acuity at onset and final visual outcome were 20/83 and 20/45, respectively, an insignificant improvement. Vision improved in 48% of cases. A marked heterogeneity in treatment approach was found. Eight (28%) patients received no therapy, whereas for 21 (72%) a large variety of topical and/or systemic drugs was given. In the treated group, mean visual acuity at onset and final visual outcome were 20/90 and 20/44, respectively, a not statistically significant improvement. Results suggest that combined BRAO + CRVO occurs at a younger age than isolated BRAO or CRVO. At present, there is insufficient evidence to support any specific management to improve vision in simultaneous BRAO + CRVO.

摘要

我们进行了一项系统综述,并分析了目前关于视网膜分支动脉阻塞(BRAO)合并视网膜中央静脉阻塞(CRVO)这一罕见情况的可用数据。根据MOOSE指南,在MEDLINE/PubMed和ISI Web of Sciences数据库中进行了检索。如果研究(1)描述了BRAO合并CRVO的患者,且(2)发表在同行评审期刊上,则被认为符合纳入标准。我们最初从数据库中识别出239条记录。最终,只有19份报告符合入选标准。对29例患者(15例男性,14例女性;平均年龄43±15岁)进行了分析。17例(59%)患者存在血管危险因素。发病时的平均视力和最终视力结果分别为20/83和20/45,改善不显著。48%的病例视力有所改善。发现治疗方法存在显著异质性。8例(28%)患者未接受治疗,而21例(72%)患者接受了多种局部和/或全身药物治疗。在治疗组中,发病时的平均视力和最终视力结果分别为20/90和20/44,改善无统计学意义。结果表明,BRAO合并CRVO比孤立的BRAO或CRVO发病年龄更小。目前,没有足够的证据支持对BRAO合并CRVO采取任何特定的改善视力的治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验